Drug Discovery World

NOVEMBER 27, 2023

As the significance of large molecules continues to broaden across diverse modalities, emphasis on bispecific and multispecific antibodies to treat various disorders such as rheumatologic diseases, cancer, diabetes, anaemia, and infectious diseases becomes paramount. Biotechnol Bioeng 2012;118:2326. Budge JD, Knight TJ, Povey J, et al.

Production 147

Production Engineering Molecular Biology Drug Development 147

The Pharma Data

DECEMBER 3, 2020

The disease is classified as a developmental and epileptic encephalopathy due to the developmental delays and cognitive impairment associated with the disease. Chief Medical Officer of Stoke Therapeutics. BEDFORD, Mass.–( –( BUSINESS WIRE )– Stoke Therapeutics , Inc. Devices, Technologies, Stem Cells.

Protein Expression 52

Protein Expression Clinical Trials Pharmacokinetics Trials 52

The Pharma Data

JANUARY 24, 2021

A key advantage of Elasmogen’s VNAR platform is the ability to bind to their target at sites that are inaccessible to human antibodies translating, in many cases, to increased potency and specificity against the disease. We then screened these for VNAR binders that block viral infection, and are delighted with the outcomes.”

Research 52

Research Virus Medical Schools Government 52